AcquisitionsJun 24, 2026, 09:03 AM
Strata Critical Medical Acquires HLT-NRP for $21.5M
AI Summary
Strata Critical Medical, Inc. has completed the acquisition of Heart and Lung Transplant National Recovery Program (HLT-NRP) for $21.5 million. This strategic move significantly strengthens Strata's organ recovery platform by expanding its network of experienced transplant surgeons and increasing its clinical depth and geographic reach in key markets. The acquisition, funded by 80% cash and 20% stock, is expected to add $10.0 million in revenue and $3.1 million in Adjusted EBITDA for HLT-NRP in the full year 2026, aligning with Strata's capital deployment strategy.
Key Highlights
- Strata Critical Medical acquired Heart and Lung Transplant National Recovery Program (HLT-NRP).
- The acquisition was valued at $21.5 million.
- Transaction funded with approximately 80% cash and 20% stock.
- HLT-NRP adds significant scale to Strata's Transplant Clinical business line.
- Acquisition completed at a mid-single-digit multiple of Adjusted EBITDA, pre-synergy.
- HLT-NRP is expected to generate $10.0 million in revenue for full year 2026.
- HLT-NRP is expected to generate $3.1 million in Adjusted EBITDA for full year 2026.
- The acquisition expands Strata's network of transplant surgeons and geographic reach.
Price Impact
More from SRTA